{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T05:07:58Z","timestamp":1767503278957,"version":"3.48.0"},"reference-count":33,"publisher":"The Royal Society","issue":"1278","license":[{"start":{"date-parts":[[1988,10,22]],"date-time":"1988-10-22T00:00:00Z","timestamp":593481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/royalsociety.org\/journals\/ethics-policies\/data-sharing-mining\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1988,10,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immunoglobulin G (IgG) from Lambert-Eaton myasthenic syndrome (LEMS) patients acts at motor nerve terminal Ca2+ channels. It was injected into mice to investigate effects on cardiac Ca2+ channels. Intracellular recordings were made of slow action potentials in right ventricular muscle cells in the presence of high K+ concentrations and isoprenaline (1\u00b5M). Reduction in Ca2+ concentration reduced the rate of rise and amplitude, but not the duration, of slow action potentials whereas verapamil (1\u00b5M) blocked them. They were not blocked by tetrodotoxin (10 \u00b5M), and 4-aminopyridine (1mM) prolonged the decay phase without affecting the rate of rise and amplitude. The rate of rise, amplitude and duration of slow action potentials were not affected by LEMS IgG. These results show that LEMS IgG does not act on Ca2+ channel currents that underlie slow action potentials in mouse ventricles, suggesting antigenic differences between Ca2+ channels at motor nerve terminals and heart.<\/jats:p>","DOI":"10.1098\/rspb.1988.0065","type":"journal-article","created":{"date-parts":[[2006,12,18]],"date-time":"2006-12-18T18:20:27Z","timestamp":1166466027000},"page":"103-110","source":"Crossref","is-referenced-by-count":6,"title":["The effect of Lambert-Eaton myasthenic syndrome antibody on slow action potentials in mouse cardiac ventricle"],"prefix":"10.1098","volume":"235","author":[{"given":"B.","family":"Lang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Newsom-Davis","sequence":"additional","affiliation":[{"name":"Institute of Molecular Medicine, John Radcliffe Hospital, Oxford OX3 9DU, U. K."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. W.","family":"Wray","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Royal Free Hospital School of Medicine, Rowland Hill Street, London NW3 2PF, U. K."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"175","reference":[{"key":"p_1","first-page":"1","article-title":"Two kinds of calcium channels in canine atrial cells. Differences in kinetics, selectivity and pharmacology. J.gen","volume":"86","author":"Bean B. P.","year":"1985","journal-title":"Physiol."},{"key":"p_2","doi-asserted-by":"publisher","DOI":"10.1098\/rspb.1980.0155"},{"key":"p_3","doi-asserted-by":"crossref","unstructured":"Burges J. & W.-Wray D. 1988 Effect of the calcium channel agonist CGP 28392 on transmitter release at mouse neuromuscular junctions. N.Y. Acad. Sci. (In the press.)","DOI":"10.1111\/j.1749-6632.1989.tb24108.x"},{"key":"p_4","first-page":"185","article-title":"[3H]Nimodipine specific binding to cardiac myocytes and subcellular fractions. Biochem. biophys","volume":"113","author":"De Pover A.","year":"1983","journal-title":"Res. Commun."},{"key":"p_5","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880050905"},{"key":"p_6","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.80.24.7636"},{"key":"p_7","first-page":"S608","article-title":"Molecular pharmacology of the calcium channel: evidence for subtypes, multiple drug-receptor sites, channel subunits, and the development of a radioiodinated 1,4-dihydropyridine calcium channel label, [1251]iodipine. J. cardiovasc","volume":"6","author":"Glossmann H.","year":"1984","journal-title":"Pharmac."},{"key":"p_8","first-page":"415","article-title":"Effect of substances blocking calcium channels (verapamil, D600, manganese ions) on transmitter release from motor nerve endings in frog muscle","volume":"9","author":"Gotgilf M.","year":"1977","journal-title":"Neurophysiology"},{"key":"p_9","doi-asserted-by":"crossref","unstructured":"Horejsi J. & Smetana R. 1956 The isolation of gamma globulin from blood-serum by rivanol. Acta med. scand. 155 65-70.","DOI":"10.1111\/j.0954-6820.1956.tb14351.x"},{"key":"p_10","first-page":"139","article-title":"4-aminopyridine and the early outward current of sheep cardiac purkinje fibers. J . gen","volume":"73","author":"Kenyon J. L.","year":"1979","journal-title":"Physiol."},{"key":"p_11","doi-asserted-by":"publisher","DOI":"10.1038\/308282a0"},{"key":"p_12","doi-asserted-by":"publisher","DOI":"10.1002\/mus.880080213"},{"key":"p_13","doi-asserted-by":"publisher","DOI":"10.1126\/science.2447652"},{"key":"p_14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1971.tb30750.x"},{"key":"p_15","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(81)90474-8"},{"key":"p_16","first-page":"335","article-title":"Antibodies to motor nerve terminals: an electrophysiological study of a human myasthenic syndrome transferred to mouse. J . Physiol","volume":"344","author":"Lang B.","year":"1983","journal-title":"Lond."},{"key":"p_17","first-page":"94P","article-title":"Effect of Lam bert-Eaton myasthenic syndrome antibody on mouse ventricular muscle. J . Physiol","volume":"369","author":"Lang B.","year":"1985","journal-title":"Lond."},{"key":"p_18","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.1987.sp016698"},{"key":"p_19","first-page":"43P","article-title":"6 Selective action of Lam bert-Eaton myasthenic syndrome antibodies on Ca 2+ channels in the neuroblastoma x glioma hybrid cell line NG108 15. J. Physiol","volume":"394","author":"Lang B.","year":"1987","journal-title":"Lond."},{"key":"p_20","unstructured":"McCleskey E. W. Fox A. P. Feldman D. Olivera B. M. Tsien R. W. & Yoshikami D. 1986 The peptide toxin wCgTX blocks particular types of neuronal Ca channels. Biophys. J . 49. 431a."},{"key":"p_21","first-page":"551","article-title":"Strontium, nifedipine and 4- aminopyridine modify the time course of the action potential in cells from rat ventricular muscle. Br. J","volume":"81","author":"Mitchell M. R.","year":"1984","journal-title":"Pharmac."},{"key":"p_22","first-page":"162","article-title":"Comparison of the effects of several calcium antagonistic drugs (slow channel blockers) on the electrical and mechanical activities of guinea pig papillary muscle. J . cardiovasc","volume":"5","author":"Molyvdas P.-A.","year":"1983","journal-title":"Pharmac."},{"key":"p_23","first-page":"579","article-title":"The effect of some organic \" calcium antagonists","volume":"16","author":"Nachshen D. A.","year":"1979","journal-title":"Molec. Pharmac."},{"key":"p_24","doi-asserted-by":"publisher","DOI":"10.1038\/316443a0"},{"key":"p_25","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/111.3.577"},{"key":"p_26","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410170610"},{"key":"p_27","doi-asserted-by":"publisher","DOI":"10.1038\/301569a0"},{"key":"p_28","doi-asserted-by":"publisher","DOI":"10.1038\/317737a0"},{"key":"p_29","doi-asserted-by":"publisher","DOI":"10.1126\/science.2420007"},{"key":"p_30","doi-asserted-by":"crossref","unstructured":"Rubenstein A. E. Horowitz S. H. & Bender A. N. 1979 Cholinergic dysautonomia and Eaton-Lambert syndrome. Neurology Minnea720-723.","DOI":"10.1212\/WNL.29.5.720"},{"key":"p_31","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5320(82)90078-8"},{"key":"p_32","doi-asserted-by":"publisher","DOI":"10.1007\/BF00217570"},{"key":"p_33","first-page":"37","article-title":"Prolonged exposure to acetylcholine: noise analysis and channel inactivation in cat tenuissimus muscle. J . Physiol","volume":"310","author":"Wray D.","year":"1981","journal-title":"Lond."}],"container-title":["Proceedings of the Royal Society of London. Series B. Biological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/royalsocietypublishing.org\/doi\/pdf\/10.1098\/rspb.1988.0065","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/royalsocietypublishing.org\/rspb\/article-pdf\/235\/1278\/103\/174161\/rspb.1988.0065.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/royalsocietypublishing.org\/rspb\/article-pdf\/235\/1278\/103\/174161\/rspb.1988.0065.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T05:06:55Z","timestamp":1767503215000},"score":1,"resource":{"primary":{"URL":"https:\/\/royalsocietypublishing.org\/rspb\/article\/235\/1278\/103\/34025\/The-effect-of-Lambert-Eaton-myasthenic-syndrome"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,10,22]]},"references-count":33,"journal-issue":{"issue":"1278","published-print":{"date-parts":[[1988,10,22]]}},"URL":"https:\/\/doi.org\/10.1098\/rspb.1988.0065","relation":{},"ISSN":["0080-4649","2053-9193"],"issn-type":[{"type":"print","value":"0080-4649"},{"type":"electronic","value":"2053-9193"}],"subject":[],"published":{"date-parts":[[1988,10,22]]}}}